FDA reverses course on Regenxbio’s childhood gene therapy after rejection Agency’s decision to reconsider is latest in a series of turnabouts

https://www.statnews.com/2026/06/22/fda-reverses-course-regenxbio-gene-therapy-navsunli-hunter-syndrome/ By Jason MastJune 22, 2026 General Assignment Reporter